Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial

BACKGROUND: The potential of neuroprotective agents should be revisited in the era of endovascular thrombectomy (EVT) for acute large-artery occlusion because their preclinical effects have been optimized for ischemia and reperfusion injury. Neu2000, a derivative of sulfasalazine, is a multi-target...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Ji Man, Choi, Mun Hee, Sohn, Sung-Il, Hwang, Yang-Ha, Ahn, Seong Hwan, Lee, Yeong-Bae, Shin, Dong-Ick, Chamorro, Ángel, Choi, Dennis W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045859/
https://www.ncbi.nlm.nih.gov/pubmed/30005644
http://dx.doi.org/10.1186/s13063-018-2746-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045859/
https://www.ncbi.nlm.nih.gov/pubmed/30005644
http://dx.doi.org/10.1186/s13063-018-2746-9

Ejemplares similares